...
首页> 外文期刊>International journal of colorectal disease. >Fibrin glue and transanal rectal advancement flap for high transsphincteric perianal fistulas; is there any advantage?
【24h】

Fibrin glue and transanal rectal advancement flap for high transsphincteric perianal fistulas; is there any advantage?

机译:纤维蛋白胶和经肛门直肠瓣治疗高位括约肌肛周瘘有什么好处吗?

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUNDS AND AIM: In recent decades, fibrin glue has appeared as an alternative treatment for high perianal fistulas. Early results seemed promising, with high success rates being reported. However, with increasing follow-up, the enthusiasm was tempered because of disappointing results. The aim of this retrospective study was to assess the additional value of fibrin glue in combination with transanal advancement flap, compared to advancement flap alone, for the treatment of high transsphincteric fistulas of cryptoglandular origin. MATERIALS AND METHODS: Between January 1995 and January 2006, 127 patients were operated for high perianal fistulas with an advancement flap. After exclusion of patients with inflammatory bowel disease or HIV, 80 patients remained. A consecutive series of 26 patients had an advancement flap combined with obliteration of the fistula tract with fibrin glue. Patients were matched for prior fistula surgery, and the advancement was performed identically in all patients. In the fibrin glue group, glue was installed retrogradely in the fistula tract after the advancement was completed and the fistula tract had been curetted. RESULTS: Minimal follow-up after surgery was 13 months [median of 67 months (range, 13-127)]. The overall recurrence rate was 26% (n=21). Recurrence rates for advancement flap alone vs the combination with glue were 13% vs 56% (p=0.014) in the group without previous fistula surgery and 23% vs 41% (p=0.216) in the group with previous fistula surgery. CONCLUSION: Obliterating the fistula tract with fibrin glue was associated with worse outcome after rectal advancement flap for high perianal fistulas.
机译:背景与目的:近几十年来,纤维蛋白胶已成为肛周瘘管的一种替代治疗方法。早期结果似乎很有希望,据报道成功率很高。但是,随着随访的增加,由于令人失望的结果,热情有所降低。这项回顾性研究的目的是评估与单独行进皮瓣相比,结合纤维蛋白胶与经肛门行皮瓣治疗高位经隐括约肌括约肌瘘的价值。材料与方法:在1995年1月至2006年1月之间,有127例因肛周瘘管高位行皮瓣手术。在排除炎症性肠病或HIV患者后,剩下80名患者。连续的26例患者有进展性皮瓣合并纤维蛋白胶封闭瘘管。对患者进行了先前的瘘管手术匹配,并且所有患者的进展均相同。在纤维蛋白胶组中,在推进完成并且将瘘管刮过之后,将胶逆行地安装在瘘管中。结果:术后最少随访时间为13个月[中位数为67个月(范围13-127)]。总体复发率为26%(n = 21)。不进行瘘管手术的组单独进行皮瓣与结合使用胶水的复发率分别为13%和56%(p = 0.014),进行瘘管手术的组分别为23%vs 41%(p = 0.216)。结论:高位肛周瘘管直肠扩张皮瓣后,用纤维蛋白胶清除瘘管与预后较差有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号